An investigation on behalf of investors in Surface Oncology, Inc. (NASDAQ: SURF) shares over potential wrongdoing at Surface Oncology, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 11/06/2019 -- Certain directors of Surface Oncology, Inc. are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of Surface Oncology, Inc. (NASDAQ: SURF) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Surface Oncology directors breached their fiduciary duties and caused damage to the company and its shareholders.
Cambridge, MA based Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. Surface Oncology, Inc completed its initial public offering ("IPO") on April 23, 2018, offering shares at $15.00. Surface Oncology, Inc. reported that its annual Total Revenue rose from $12.82 million in 2017 to $59.41 million in 2018 and that its Net Loss declined from $445.37 million in 2017 to $6.59 million in 2018.
Shares of Surface Oncology, Inc. (NASDAQ: SURF) declined from $17.22 per share on July 2, 2018 to as low as $1.15 per share on October 1, 2019.
Those who purchased shares of Surface Oncology, Inc. (NASDAQ: SURF) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels